Biotherapeutics & Bioinnovation Center
Organized in 2007 and based in California's Bay Area, the Biotherapeutics and Bioinnovation Center (BBC) advances Pfizer's commitment to excellence in biotherapeutics leadership by bringing together the right resources, alliances, products and people. This new, separate research and development (R&D) division combines cutting-edge biology, advanced biologic technologies and innovative R&D approaches to develop new, high-quality medicines, and in so doing, propel Pfizer to the forefront of bioinnovation and into the top tier of biotherapeutic companies.
"Pfizer is committed to flexible, transparent and mutually beneficial long-term relationships with its partners. By joining forces, we can bring quality therapies to patients worldwide. Let's work together for a healthier world."
—Bill Ringo, Senior Vice President,
Worldwide Business Development
Strategy & Innovation
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2009 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
